In Q1 FY2026 (ended March 31, 2026), Orthofix Medical Inc. reported revenue of $196.7 million, up 1.6% year-over-year. Net loss narrowed to $20.9 million from $53.2 million a year ago, a 60.6% improvement. Operating loss improved to $14.4 million from $48.8 million. Diluted EPS was -$0.52, compared to -$1.35 in the prior year period.
•Revenue increased 1.6% YoY to $196.7 million.
•Net loss improved 60.6% to $20.9 million.
•Operating loss improved 70.5% to $14.4 million.
•Diluted EPS was -$0.52, up from -$1.35.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Orthofix Medical is a medical technology company globally. Its business is organized into two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion.
Its portfolio also includes designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column, and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions.
This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations
7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market Including deformity correction, limb lengthening, complex fracture management, and limb preservation.
This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. Founded in 1980 and headquartered in Lewisville, Texas, Orthofix Medical was formerly known as Orthofix International N.V. before rebranding in July 2018.
Orthofix Medical Inc. is a medical technology company that operates through two segments: Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures bone growth stimulation devices to enhance bone fusion, designs and markets spine fixation implant products for the spinal column, and offers bone graft substitutes like demineralized bone matrices, cellular bone allografts, and synthetic bone void fillers. It also provides navigation technologies, including the 7D FLASH Navigation System for spinal and cranial procedures. The Global Limb Reconstruction segment focuses on the limb reconstruction market, offering products for deformity correction, limb lengthening, complex fracture management, and limb preservation, including external and internal fixation devices coupled with digital technologies.
Where is Orthofix Medical Inc. (OFIX) listed and in what currency?
Orthofix Medical Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol OFIX. Its financials are reported in US Dollars (USD), as the company is based in the United States.
What sector and industry does Orthofix Medical Inc. (OFIX) belong to?
Orthofix Medical Inc. operates in the Healthcare sector and specifically within the Medical Devices industry. This means the company develops and sells medical equipment and technologies used by healthcare professionals to treat patients, particularly in spinal and orthopedic care.
What are the main products and technologies offered by Orthofix Medical Inc. (OFIX)?
Orthofix Medical Inc. offers a wide range of products across two segments. In the Global Spine segment, key products include bone growth stimulation devices, spine fixation implants, and bone graft substitutes such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers. The segment also provides navigation technologies like tracked surgical tools, intelligent software, and the 7D FLASH Navigation System for spinal and cranial procedures. In the Global Limb Reconstruction segment, products include external and internal fixation devices for deformity correction, limb lengthening, complex fracture management, and limb preservation, supported by digital technologies for patient care.
How does Orthofix Medical Inc. (OFIX) distribute its products?
Orthofix Medical Inc. sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. This distribution model allows the company to reach a broad customer base in the medical device market, leveraging both direct and indirect channels to deliver its spinal and limb reconstruction solutions globally.